11.2. Analysis.
Comparison 11: Platinum vs non‐platinum regimens (sensitivity analysis 4: mTNBC patients selected for trial vs. a subgroup of trial), Outcome 2: Progression‐free survival/time to progression
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.